

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Among its major competitors, Edwards Lifesciences is ranked in 9th place for NPS while Symmetry Surgical is 1st, and Medtronic is 2nd.Their current market cap is $51.64B